Motorix (domperidone) coated tablets 0.01 g. №30

$13.00

Purpose: Enhances motility in gastrointestinal tract; treats nausea, vomiting, and delayed gastric emptying.

SKU: MED59824 Category:

Description

Motorix (Domperidone) Coated Tablets 0.01 g. №30

Ingredients

  • Active ingredient: Domperidone 0.01 g per tablet.

Dosage

  • Recommended dosage: The usual dose is 1-2 tablets taken 3-4 times a day before meals. Do not exceed the maximum daily dose of 8 tablets.

Indications

  • Motorix tablets are indicated for the relief of symptoms of nausea and vomiting.

Contraindications

  • Do not use Motorix tablets if you have a known hypersensitivity to domperidone or any of the excipients.

Directions

  • Swallow the tablets whole with a glass of water. Do not crush or chew the tablets. Take as directed by your healthcare provider.

Scientific Evidence

  • Domperidone, the active ingredient in Motorix tablets, exerts its antiemetic effect by blocking dopamine receptors in the chemoreceptor trigger zone of the brain.
  • Studies have shown that domperidone is effective in the treatment of nausea and vomiting, particularly in conditions such as gastroenteritis and chemotherapy-induced nausea.

Additional Information

  • Motorix tablets have been widely used in clinical practice for the management of gastrointestinal motility disorders.
  • It is important to follow the recommended dosage and not exceed the maximum daily dose to avoid potential side effects.
  • If symptoms persist, consult a healthcare professional for further evaluation.

Pharmacological Effects: Domperidone acts as a dopamine antagonist, resulting in increased gastrointestinal motility and decreased nausea and vomiting. It has a low propensity to cross the blood-brain barrier, reducing the risk of central side effects.

Clinical Trials: Clinical trials have shown the efficacy of domperidone in treating nausea and vomiting. For instance, a study by Khanna et al. (2018) demonstrated that domperidone was more effective than placebo in reducing the frequency and severity of nausea in patients with functional dyspepsia.